Skip to main content
SpringerLink
Log in

Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Osteogenesis imperfecta (OI) is a result of heterozygous mutations in the COL1A1 or COL1A2 genes, encoding type I procollagen chains. Here we described the molecular and biochemical defects detected in a case of severe type III OI. Cultured skin fibroblasts from the proband produced both normal and mutant type I collagen which was secreted into the medium. The mutation site was localized in α1(I)-CB3 by CNBr cleavage of collagen chains. Subsequent reverse transcription-PCR amplification and direct sequencing of single-stranded PCR product led to identification of G to A transition in the COL1A1 gene, resulting in Gly511Ser substitution in the a1 chain of type I collagen. The new mutation conforms to the chain-specific non-lethal microdomain of Gly to Ser substitutions in the genotype-phenotype map.

We have found that biosynthesis of collagen was increased in OI cells to about 160% of the control value. However, the amount of collagen deposed to the insoluble matrix was decreased as compared to the control. This suggests increased degradation of collagen, since the collagenolytic activity of OI cells was increased. Furthermore, the activity of prolidase, which is a marker of collagen turnover, was increased in OI cells. In regulation of activity of the enzyme are involved β1 integrin and insulin-like growth factor (IGF) receptors. Western immunoblot analysis showed that the expressions of both receptors were markedly increased in OI cells. These results suggest that increase in activity of prolidase can be associated with increase in intensity of collagen metabolism in type III OI patient with identified new G511S mutation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sillence DO, Senn A, Danks DM: Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16: 101-116, 1979

    Google Scholar 

  2. Prockop DJ: Mutations in collagen genes as a cause of connective-tissue diseases. N Engl J Med 326: 540-546, 1992

    Google Scholar 

  3. Byers PH: Disorders of collagen biosynthesis and structure. In: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (eds). The Metabolic Basis of Inherited Disease. McGraw Hill, New York, 1989, pp 2805-2842

    Google Scholar 

  4. Dalgleish R: The human type I collagen database. Nucleic Acids Res 25: 181-187, 1997

    Google Scholar 

  5. Cole WG: The molecular pathology of osteogenesis imperfecta. Clin Orthop Rel Res 343: 235-248, 1997

    Google Scholar 

  6. Jackson SH, Dennis AN, Greenberg M: Iminopeptiduria. A genetic defect in recycling collagen; a method for determining prolidase in red blood cells. Can Med Ass J 113: 759-763, 1975

    Google Scholar 

  7. Phang JM, Scriver CR: Disorders of proline and hydroxyproline metabolism. In: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (eds). The Metabolic Basis of Inherited Disease. McGraw Hill, New York, 1989, pp 577-597

    Google Scholar 

  8. Yaron A, Naider F: Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28: 31-81, 1993

    Google Scholar 

  9. Emmerson KS, Phang JM: Hydrolysis of proline dipeptides completely fulfills the proline requirement in a proline-auxotropic Chinese Hamster Ovary cell line. J Nutr 123: 909-914, 1993

    Google Scholar 

  10. Bonadio J, Holbrook KA, Gelinas RE, Jacob J, Byers PH: Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem 260: 1734-1742, 1985

    Google Scholar 

  11. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227: 680-685, 1970

    Google Scholar 

  12. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987

    Google Scholar 

  13. Sanger F, Nicklin S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467, 1997

    Google Scholar 

  14. Oyamada I, Pałka J, Schalk EM, Takeda K, Peterkofsky B: Scorbutic and fasted guinea pig sera contain an insulin-like growth factor-I reversible inhibitor of proteoglycan and collagen synthesis in chick embryo chondrocytes and adult human skin fibroblasts. Arch Biochem Biophys 276: 85-93, 1990

    Google Scholar 

  15. Peterkofsky B, Chojkier M, Bateman J: Determination of collagen synthesis in tissue and cell culture system. In: M. Furthmay (ed). Immunochemistry of the Extracellular Matrix. CRC Press, Boca Raton, Fl, 1982, pp 19-47

    Google Scholar 

  16. Myara I, Charpentier C, Lemonnier A: Optimal conditions for prolidase assay by proline colorimetric determination: Application to imidodipeptiduria. Clin Chim Acta 125: 193-205, 1982

    Google Scholar 

  17. Chinard FP: Photometric estimation of proline and ornithine. J Biol Chem 199: 91-95, 1952

    Google Scholar 

  18. Lowry OH, Rosenbergh NI, Farr AL, Randall IR: Protein measurement with the folin reagent. J Biol Chem 193: 265-275, 1951

    Google Scholar 

  19. Unemori EN, Werb Z: Reorganization of polymerized actin: A possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 103: 1021-1031, 1986

    Google Scholar 

  20. Miltyk W, Karna E, Wołczyński S, Pałka J: Insulin-like growth factor-I-dependent regulation of prolidase activity in cultured human skin fibroblasts. Mol Cell Biochem 189: 177-184, 1998

    Google Scholar 

  21. Pałka JA, Phang J: Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 67: 166-175, 1997

    Google Scholar 

  22. Marini JC, Lewis MB, Wang Q, Chen KJ, Orrison BM: Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. J Biol Chem 268: 2667-2673, 1993

    Google Scholar 

  23. Scott JE: Proteoglycan-fibrillar collagen interactions. Biochem J 252: 313-323, 1988

    Google Scholar 

  24. Pepin M, Atkinson M, Starman BJ, Byers PH: Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: A review of biochemical and molecular studies completed in 129 pregnancies. Prenat Diagn 17: 559-570, 1997

    Google Scholar 

  25. Mottes M, Gomez Lira M, Zolezzi F, Valli M, Lisi V, Freising P: Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Hum Mutat 12: 71-72, 1998

    Google Scholar 

  26. Ward LM, Lalic L, Roughley PJ, Glorieux FH: Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I–IV. Hum Mutat 17: 434, 2001

    Google Scholar 

  27. Mackay K, Byers PH, Dalgleish R: An RT-PCR-SSCP strategy for detection of mutations in the gene encoding the alpha 1 chain of type I collagen: Application to four patients with osteogenesis imperfecta. Hum Mol Genet 2: 1155-1160, 1993

    Google Scholar 

  28. Rose NJ, Mackay K, De Paepe A, Steinmann B, Punnett HH, Dalgleish R: Three unrelated individuals with perinatally lethal osteogenesis imperfecta resulting from identical Gly502Ser substitution in the alpha 2-chain of type I collagen. Hum Genet 94: 497-503, 1994

    Google Scholar 

  29. Galicka A, Wołczyński S, Anchim T, Surażyński A, Lesniewicz R, Pałka J: Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta. Eur J Biochem 268: 2172-2178, 2001

    Google Scholar 

  30. Miltyk W, Karna E, Pałka J: Inhibition of prolidase activity by nonsteroid antiinflammatory drugs in cultured human skin fibroblasts. Pol J Pharmacol 48: 609-613, 1996

    Google Scholar 

  31. Pałka J, Miltyk W, Karna E, Wołczyński S: Modulation of prolidase activity during in vitro aging of human skin fibroblasts the role of extracellular matrix collagen. Tokai J Exp Clin Med 21: 207-213, 1996

    Google Scholar 

  32. Pałka JA, Karna E, Miltyk W: Fibroblast chemotaxis and prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate. Mol Cell Biochem 168: 177-183, 1997

    Google Scholar 

  33. Miltyk W, Pałka JA: Potential role of pyrroline 5-carboxylate in regulation of collagen biosynthesis in cultured human skin fibroblasts. Comp Biochem Physiol (part A) 125: 265-271, 2000

    Google Scholar 

  34. Myara I, Miech G, Fabre M, Mangeot M, Lemonnier A: Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Brit J Exp Pathol 68: 7-13, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Chemistry, Medical Academy of Białystok, 15-230, Białystok 8, Poland

    Anna Galicka & Andrzej Gindzienński

  2. Department of Gynaecological Endocrinology, Medical Academy of Białystok, 15-230, Białystok 8, Poland

    Sławomir Wołczyński

  3. Department of Medicinal Chemistry, Medical Academy of Białystok, 15-230, Białystok 8, Poland

    Arkadiusz Surażyński & Jerzy Pałka

Authors
  1. Anna Galicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sławomir Wołczyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrzej Gindzienński
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arkadiusz Surażyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jerzy Pałka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galicka, A., Wołczyński, S., Gindzienński, A. et al. Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen. Mol Cell Biochem 248, 49–56 (2003). https://doi.org/10.1023/A:1024197213525

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024197213525

Search

Navigation